ARDT — Ardent Health, Inc. Stock Price, Chart & AI Report

Negative Mar 8, 2026 • 21:24 UTC GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.

ARDENT HEALTH FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights

A class action lawsuit has been filed against Ardent Health, Inc. for allegedly reporting inflated accounts receivable and delaying loss recognition on uncollectable accounts during the class period of July 18, 2024 to November 12, 2025. The company revealed a $43 million revenue decrease in Q3 2025 after transitioning to a new accounting system, causing the stock to plummet 34% from $14.05 to $9.30 per share. Investors have until March 9, 2026 to apply as lead plaintiff.

ARDT class action lawsuit accounts receivable revenue restatement accounting fraud stock price decline securities litigation

Sentiment note

The company faces allegations of accounting improprieties including inflated accounts receivable reporting and delayed loss recognition. A significant $43 million revenue restatement triggered a 34% stock price decline, indicating serious financial and operational issues that harm investor interests.

Negative Mar 8, 2026 • 16:00 UTC GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Ardent Health, Inc. alleging that the company made materially false and misleading statements regarding its Q3 2025 revenue and 2025 EBITDA guidance. The complaint claims revenue was overstated due to inadequate accounts receivable assessments following a new accounting system implementation, and EBITDA guidance was overstated by approximately $57.5 million (9.6%) due to industry-wide cost pressures and payer denials. Investors who purchased Ardent securities between July 18, 2024 and November 12, 2025 are encouraged to join the lawsuit.

ARDT class action lawsuit securities fraud revenue overstatement EBITDA guidance accounts receivable investor harm federal securities laws

Sentiment note

The company is accused of making materially false and misleading statements about its financial performance, specifically overstating Q3 2025 revenue and 2025 EBITDA guidance. These allegations of securities fraud and accounting irregularities represent significant legal and reputational risks to the company and its investors.

Negative Mar 8, 2026 • 14:41 UTC GlobeNewswire Inc. • Rosen Law Firm

EDR IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endeavor Group Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 18 Deadline in Securities Class Action - EDR

Rosen Law Firm is notifying investors in Endeavor Group Holdings (EDR), Ardent Health (ARDT), and BellRing Brands (BRBR) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege false and misleading statements regarding share valuations, executive compensation disclosures, and conflicts of interest in merger-related filings.

ARDT BRBR securities class action lead plaintiff deadline false and misleading statements merger investor losses SEC filings

Sentiment note

Company is subject to securities class action lawsuit with an imminent lead plaintiff deadline, indicating alleged securities violations affecting investors.

Negative Mar 8, 2026 • 14:11 UTC GlobeNewswire Inc. • Rosen Law Firm

BRBR IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BellRing Brands, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BRBR

Rosen Law Firm is encouraging investors with significant losses to join multiple securities class action lawsuits. BellRing Brands faces allegations that reported sales growth was driven by customer inventory stockpiling rather than genuine consumer demand, with the company downplaying competitive pressures. The lead plaintiff deadline for BellRing is March 23, 2026.

BRBR ARDT securities class action investor losses BellRing Brands inventory stockpiling misleading statements competitive pressures

Sentiment note

Subject of a securities class action lawsuit with a final deadline of March 9, 2026, indicating alleged securities violations and investor losses.

Negative Mar 8, 2026 • 14:11 UTC GlobeNewswire Inc. • Rosen Law Firm

ARDT FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ardent Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT

A securities class action lawsuit has been filed against Ardent Health, Inc. for alleged misrepresentations regarding accounts receivable accounting practices and insufficient professional malpractice liability insurance. The lawsuit claims defendants misled investors about their accounts receivable monitoring processes and used a 180-day cliff accounting method to delay recognizing uncollectible accounts. Investors with losses exceeding $100K are encouraged to join the class action before the March 9, 2026 lead plaintiff deadline.

ARDT securities class action accounts receivable misrepresentation professional malpractice insurance lead plaintiff deadline investor losses

Sentiment note

The company is the subject of a securities class action lawsuit alleging material misrepresentations regarding accounts receivable accounting practices and insufficient insurance coverage. Defendants allegedly used deceptive accounting methods to inflate reported receivables and delay loss recognition, resulting in investor damages when the truth was revealed.

Negative Mar 7, 2026 • 11:18 UTC GlobeNewswire Inc. • Bfa Law

$ARDT Class Reminder: Ardent Health Investors Reminded of the Monday March 9 Securities Class Action Deadline – Investors with Losses Urged to Contact BFA Law

BFA Law has filed a securities class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) alleging the company misrepresented its receivables collection practices and delayed recognition of uncollectable accounts. The lawsuit was triggered by a 33% stock drop on November 13, 2025, following Ardent Health's disclosure of a $43 million revenue decrease and $54 million increase in professional liability reserves. Investors have until March 9, 2026, to request lead plaintiff status.

ARDT securities fraud class action lawsuit receivables misrepresentation stock decline uncollectable accounts federal securities laws

Sentiment note

Company is subject to securities fraud allegations involving misrepresentation of receivables and collection practices, resulting in a 33% stock price decline and significant financial restatements ($43 million revenue decrease and $54 million liability reserve increase).

Negative Mar 7, 2026 • 11:17 UTC GlobeNewswire Inc. • Bfa Law

$DRVN Investigation News: Driven Brands Investors Notified of the Ongoing Securities Investigation – Investors with Losses Urged to Contact BFA Law

Bleichmar Fonti & Auld LLP is investigating Driven Brands Holdings Inc. (NASDAQ: DRVN) for potential securities fraud following a 30% stock decline on February 25, 2026. The company announced it would restate financial statements from 2023-2025 due to material accounting errors including lease accounting mistakes, cash reconciliation issues, and inappropriate revenue recognition. Material weaknesses in internal controls were also identified.

DRVN ARDT SMR securities fraud financial restatement accounting errors internal controls class action lawsuit

Sentiment note

Referenced as having an upcoming securities class action deadline (March 9), indicating ongoing litigation related to investor losses.

Negative Mar 6, 2026 • 21:00 UTC GlobeNewswire Inc. • The Gross Law Firm

Investors who lost money on Ardent Health, Inc. (ARDT) should contact The Gross Law Firm about pending Class Action - ARDT

The Gross Law Firm has filed class action lawsuits against Ardent Health, Inc. (ARDT), Kyndryl Holdings, Inc. (KD), and Ramaco Resources, Inc. (METC) for alleged securities law violations. Ardent Health is accused of misrepresenting its accounts receivable collection practices and maintaining insufficient professional liability insurance. Investors who purchased shares during specified class periods are encouraged to register as potential lead plaintiffs by the respective deadlines.

ARDT KD METC METCB class action lawsuit securities fraud accounts receivable professional liability insurance

Sentiment note

Company is accused of making false statements about accounts receivable collection practices, using a 180-day cliff method instead of detailed reviews, and maintaining insufficient professional liability insurance. These allegations indicate material misrepresentation of financial position and operational risks.

Negative Mar 5, 2026 • 03:07 UTC GlobeNewswire Inc. • The Schall Law Firm

ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025 to join a class action lawsuit. The company allegedly made false and misleading statements regarding accounts receivable collection practices and failed to maintain adequate professional malpractice liability insurance. Investors who suffered losses are encouraged to contact the firm before March 9, 2026.

ARDT securities fraud class action lawsuit accounts receivable false statements investor losses malpractice insurance

Sentiment note

The company is accused of making false and misleading statements to investors regarding accounts receivable collection practices and inadequate insurance coverage. These allegations resulted in investor losses and triggered a securities fraud class action lawsuit.

Negative Mar 4, 2026 • 17:00 UTC GlobeNewswire Inc. • Law Offices Of Howard G. Smith

DEADLINE ALERT for VRNS, ARDT, CRWV, BBWI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Varonis Systems, Ardent Health, CoreWeave, and Bath & Body Works. The lawsuits allege that defendants made false or misleading statements regarding business operations, financial performance, and risk disclosures. Investors have until mid-March 2026 to file lead plaintiff motions.

VRNS ARDT CRWV BBWI securities fraud class action lawsuit false statements misleading disclosures

Sentiment note

Alleged misrepresentation of accounts receivable collection methods, insufficient insurance coverage, and inadequate liability reserves; accused of inflating financial metrics.

Negative Mar 4, 2026 • 17:00 UTC GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Ardent Health, Inc. alleging that the company made materially false and misleading statements regarding its Q3 2025 revenue and 2025 EBITDA guidance. The complaint claims revenue was overstated due to inadequate accounts receivable assessments following a new accounting system implementation, and EBITDA guidance was overstated by approximately $57.5 million due to industry-wide cost pressures and payer denials. Investors who purchased Ardent securities between July 18, 2024 and November 12, 2025 are encouraged to join the lawsuit.

ARDT class action lawsuit securities fraud revenue overstatement EBITDA guidance accounts receivable investor harm lead plaintiff deadline

Sentiment note

The company is accused of making materially false and misleading statements about revenue and EBITDA guidance, with significant overstatements ($57.5 million EBITDA reduction) and accounting system issues affecting financial reporting accuracy. This represents serious allegations of securities fraud and investor harm.

Negative Mar 4, 2026 • 02:35 UTC GlobeNewswire Inc. • Kahn Swick & Foti, Llc

Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Ardent Health faces a securities class action lawsuit for failing to disclose material information about collections problems and revenue issues. The company revealed a $43 million revenue decrease and $57.5 million EBITDA guidance cut on November 12, 2025, triggering a 34% stock price decline. Investors have until March 9, 2026 to file lead plaintiff applications.

ARDT securities fraud class action lawsuit undisclosed collections problems revenue decrease EBITDA guidance cut stock decline accounts receivable

Sentiment note

Company faces securities fraud allegations for failing to disclose material information about collections problems. Disclosed $43 million revenue decrease, $57.5 million EBITDA guidance cut, and $54 million increase in professional liability reserves. Stock price fell 34% on the disclosure, indicating severe loss of investor confidence and significant financial deterioration.